IDYA - Company ID 0001676725
The table below shows IDEAYA Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$75.17M | -$60.34M | -$43.81M | -$27.84M | -$19.65M | -$13.72M |
| Capital expenditure | $967.00K | $1.33M | $1.32M | $43.00K | $401.00K | $1.00M |
| Investing cash flow | $118.95M | $79.82M | -$353.97M | $23.52M | -$17.76M | $36.44M |
| Dividends paid | - | - | - |
IDEAYA Biosciences, Inc. reported operating cash flow of -$71.10M for fiscal year 2025. That is up 71.3% from -$247.58M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$12.22M (FY 2017) to -$71.10M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $1.18M | $26.14M | $349.11M | $2.93M | $653.00K | $42.00M |